MLN0905 effectively kills gemcitabine-resistant pancreatic cancer cells by targeting PLK1
Abstract Background Polo-like kinase 1 (PLK1) functionally mediates tumorigenesis of pancreatic cancer (PC) and associates with its drug resistance to gemcitabine, but related inhibitor therapies were poorly explored. MLN0905 is a novel small molecule inhibitor targeting PLK1. Here we investigate th...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2025-07-01
|
| coleção: | European Journal of Medical Research |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s40001-025-02825-8 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|